Phase 2 Peritoneal Carcinomatosis Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
Peritoneal Carcinomatosis
Prakash Pandalai100 enrolled2 locationsNCT04779554
Recruiting
Phase 2
Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
Peritoneal CarcinomatosisColorectal Cancer MetastaticAppendiceal Neoplasms
Ciusss de L'Est de l'Île de Montréal25 enrolled1 locationNCT05913674
Recruiting
Phase 1Phase 2
Galunisertib Combined With Capecitabine in Advanced CRC With PM
Peritoneal CarcinomatosisColorectal Cancer Metastatic
The Netherlands Cancer Institute31 enrolled2 locationsNCT05700656
Recruiting
Phase 2
Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients
Peritoneal CarcinomatosisColo-rectal CancerPeritoneal Metastases+1 more
Michael Bau Mortensen60 enrolled1 locationNCT03280511